Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,13 USD | +214,72 % | +214,72 % | +230,97 % |
Resumen de negocios
Número de empleados: 121
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Probody Therapeutics
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 02/08/21 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/01/18 |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 56 | 17/07/23 |
Lloyd Rowland
CMP | Compliance Officer | 67 | 01/05/18 |
Jeffrey Landau
PRN | Corporate Officer/Principal | 46 | 01/04/21 |
Hong He
PRN | Corporate Officer/Principal | 55 | 01/02/20 |
Danielle Olander
HRO | Human Resources Officer | - | 01/08/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 58 | 20/12/18 |
Elaine Jones
BRD | Director/Board Member | 69 | 01/12/14 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Mani Mohindru
BRD | Director/Board Member | 52 | 16/12/20 |
Halley Gilbert
BRD | Director/Board Member | 54 | 27/04/20 |
Matthew Young
BRD | Director/Board Member | 54 | 01/11/15 |
Alan Ashworth
BRD | Director/Board Member | 63 | 29/09/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 67 731 764 | 66 926 077 ( 98,81 %) | 0 | 98,81 % |
Información de la empresa
CytomX Therapeutics, Inc.
151 Oyster Point Boulevard Suite 400
94080-1913, South San Francisco
+650 515 3185
http://www.cytomx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+230,97 % | 347 M | |
-1,17 % | 104 mil M | |
+2,87 % | 97,47 mil M | |
+2,13 % | 22,25 mil M | |
-14,77 % | 21,68 mil M | |
-8,79 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-13,21 % | 16,36 mil M | |
+8,55 % | 14,39 mil M | |
+35,75 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción CTMX
- Empresa CytomX Therapeutics, Inc.